M84.53
M84.53: Pathological fracture in neoplastic disease, ulna and radius
Non-billable headerICD-10-CM
M84.53 is a non-billable header ICD-10-CM code for pathological fracture in neoplastic disease, ulna and radius. It cannot be billed on its own: choose one of the more specific child codes below. This code also requires a 7th character before it is complete.
This code requires a 7th character
The appropriate 7th character is to be added to each code from subcategory M84.5:
- A
- initial encounter for fracture
- D
- subsequent encounter for fracture with routine healing
- G
- subsequent encounter for fracture with delayed healing
- K
- subsequent encounter for fracture with nonunion
- P
- subsequent encounter for fracture with malunion
- S
- sequela
Excludes2 inherited from the categories above M84.53
Not part of this code, but both may be coded when both are present.
Written on M84: Disorder of continuity of bone
- traumatic fracture of bone-see fracture, by site
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Code history
Unchanged in every release from FY2024 to FY2027.
Code to one of these instead M84.53
5 child codes. Green means billable.
- M84.531Pathological fracture in neoplastic disease, right ulna
- M84.532Pathological fracture in neoplastic disease, left ulna
- M84.533Pathological fracture in neoplastic disease, right radius
- M84.534Pathological fracture in neoplastic disease, left radius
- M84.539Pathological fracture in neoplastic disease, unspecified ulna and radius
Other codes under M84.5
- M84.50Pathological fracture in neoplastic disease, unspecified site
- M84.51Pathological fracture in neoplastic disease, shoulder
- M84.52Pathological fracture in neoplastic disease, humerus
- M84.54Pathological fracture in neoplastic disease, hand
- M84.55Pathological fracture in neoplastic disease, pelvis and femur
- M84.56Pathological fracture in neoplastic disease, tibia and fibula
- M84.57Pathological fracture in neoplastic disease, ankle and foot
- M84.58Pathological fracture in neoplastic disease, other specified site